Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Comparison of the in vitro antibiofilm activities of otic cleansers against canine otitis externa pathogens

View through CrossRef
AbstractBackgroundBiofilm production by canine otitis externa (COE) pathogens and resistance development to multiple antimicrobials are commonly reported problems in veterinary practice. The use of adjuvants to disrupt biofilms may be a viable adjunctive therapy.Hypothesis/ObjectivesTo compare the in vitro antibiofilm activity against COE pathogens of three otic cleansers: PHMB‐EDTA (poly [hexamethylene] biguanide hydrochloride and disodium edetate), N‐acetylcysteine (NAC) and Triz‐EDTA.Animals/IsolatesThirty isolates of each species, including Staphylococcus pseudintermedius, Pseudomonas aeruginosa, Streptococcus canis, Proteus mirabilis, Escherichia coli, and Malassezia pachydermatis, were collected from COE cases and stored at −80°C until tested.Methods and MaterialsBiofilm production was determined by Congo‐red agar and microtitre plate‐assay methods. Ten of the best biofilm‐producing isolates per species were selected to determine minimum biofilm eradication concentration (MBEC) values. Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values were determined to compare MBEC/MIC and MBEC/MBC.ResultsPHMB‐EDTA possessed antibiofilm activity at low concentrations (MBEC range 3.9/2.3–500/300 μg/mL) against all tested COE pathogens. NAC demonstrated antibiofilm activity for all tested bacterial COE pathogens (MBEC range 4,925–19,700 μg/mL); however, most M. pachydermatis isolates exhibited MBEC values >20,000 μg/mL. Triz/EDTA at the highest concentration tested (3,025/19,520 μg/mL) did not demonstrate antibiofilm activity against most COE pathogens except for S. canis (94.5/610 μg/mL).Conclusions and Clinical RelevancePHMB‐EDTA had intrinsic antibiofilm activity at low concentrations against all COE pathogens. Therefore, it is likely to be a very effective adjuvant when used in conjunction with other antimicrobials for the treatment of COE caused by biofilm‐producing pathogens.
Title: Comparison of the in vitro antibiofilm activities of otic cleansers against canine otitis externa pathogens
Description:
AbstractBackgroundBiofilm production by canine otitis externa (COE) pathogens and resistance development to multiple antimicrobials are commonly reported problems in veterinary practice.
The use of adjuvants to disrupt biofilms may be a viable adjunctive therapy.
Hypothesis/ObjectivesTo compare the in vitro antibiofilm activity against COE pathogens of three otic cleansers: PHMB‐EDTA (poly [hexamethylene] biguanide hydrochloride and disodium edetate), N‐acetylcysteine (NAC) and Triz‐EDTA.
Animals/IsolatesThirty isolates of each species, including Staphylococcus pseudintermedius, Pseudomonas aeruginosa, Streptococcus canis, Proteus mirabilis, Escherichia coli, and Malassezia pachydermatis, were collected from COE cases and stored at −80°C until tested.
Methods and MaterialsBiofilm production was determined by Congo‐red agar and microtitre plate‐assay methods.
Ten of the best biofilm‐producing isolates per species were selected to determine minimum biofilm eradication concentration (MBEC) values.
Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values were determined to compare MBEC/MIC and MBEC/MBC.
ResultsPHMB‐EDTA possessed antibiofilm activity at low concentrations (MBEC range 3.
9/2.
3–500/300 μg/mL) against all tested COE pathogens.
NAC demonstrated antibiofilm activity for all tested bacterial COE pathogens (MBEC range 4,925–19,700 μg/mL); however, most M.
 pachydermatis isolates exhibited MBEC values >20,000 μg/mL.
Triz/EDTA at the highest concentration tested (3,025/19,520 μg/mL) did not demonstrate antibiofilm activity against most COE pathogens except for S.
canis (94.
5/610 μg/mL).
Conclusions and Clinical RelevancePHMB‐EDTA had intrinsic antibiofilm activity at low concentrations against all COE pathogens.
Therefore, it is likely to be a very effective adjuvant when used in conjunction with other antimicrobials for the treatment of COE caused by biofilm‐producing pathogens.

Related Results

Otitis Externa
Otitis Externa
Otitis externa is a frequently painful inflammation widely seen in the external auditory canal, and that may be infectious or non-infectious. It can be classified according to the ...
Manejo actual de la otitis externa maligna. Una revisión sistemática.
Manejo actual de la otitis externa maligna. Una revisión sistemática.
INTRODUCCIÓN: La otitis externa maligna (OEM), o también llamada otitis externa necrotizante, es una infección potencialmente mortal, que afecta principalmente al canal auditivo ex...
Temporal bone osteomyelitis and temporoparietal abscess secondary to malignant otitis externa
Temporal bone osteomyelitis and temporoparietal abscess secondary to malignant otitis externa
AbstractObjective:We report an advanced presentation of osteomyelitis of the temporal bone secondary to malignant otitis externa.Method:We present a case report and a review of the...
Surgical Treatment of Malignant Otitis Externa MOE A New Hope Although Challenging
Surgical Treatment of Malignant Otitis Externa MOE A New Hope Although Challenging
Objective: Malignant external otitis is an aggressive inflammatory condition of the external auditory canal. Most often affects elderly patients with diabetes mellitus. This is a s...
Lipid-mediated reinforcement of FGF/MAPK signaling enables robust otic placode specification
Lipid-mediated reinforcement of FGF/MAPK signaling enables robust otic placode specification
Abstract The formation of cranial placodes requires groups of ectodermal cells to interpret inductive signals in a robust and organized manner, y...
Abstract 1772: A naturally occurring canine model of peripheral T-cell lymphoma, not otherwise specified
Abstract 1772: A naturally occurring canine model of peripheral T-cell lymphoma, not otherwise specified
Abstract Despite being the most common subtype of human peripheral T-cell lymphoma (PTCL), PTCL-not otherwise specified (PTCL-NOS) remains a poorly understood diagno...

Back to Top